Antibody Discovery News and Research

RSS
Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Turbine appoints new SAB members to guide its simulation-first drug discovery mission

Integral Molecular announces panel of P2X7 antibodies for autoimmune disorders

Integral Molecular announces panel of P2X7 antibodies for autoimmune disorders

IONTAS, Adaptate Biotherapeutics join forces to generate and optimize antibodies for novel cancer targets

IONTAS, Adaptate Biotherapeutics join forces to generate and optimize antibodies for novel cancer targets

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Streamlining Immuno-Oncological Therapeutic Antibody Discovery

Sphere Fluidics and Peak Analysis and Automation introduce integrated micro-plate handling and single cell analysis capabilities

Sphere Fluidics and Peak Analysis and Automation introduce integrated micro-plate handling and single cell analysis capabilities

We are excited to release our latest software update with new Cyto-Mine functionalities!

We are excited to release our latest software update with new Cyto-Mine functionalities!

BioStreamline: Streamlining the development of next generation biotherapeutics

BioStreamline: Streamlining the development of next generation biotherapeutics

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics closes $2 million USD (c. £1.5 million GBP) investment round

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

The Scientist names Cyto-Mine technology #1 in the Top 10 Innovations of 2018

The Scientist names Cyto-Mine technology #1 in the Top 10 Innovations of 2018

Oxford Genetics unveils OXGENE brand

Oxford Genetics unveils OXGENE brand

Rapid European adoption of Carterra’s LSA platform fuels expansion

Rapid European adoption of Carterra’s LSA platform fuels expansion

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement

IONTAS and Teva Pharmaceuticals announce new antibody optimization agreement

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

NIAID awards $22 million grant to develop antibody-based therapies against lethal viruses

IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019

IONTAS wins 'Small Business of the Year' category at Cambridge News Business Excellence Awards 2019

AvantGen and ACROBiosystems sign vendor agreement

AvantGen and ACROBiosystems sign vendor agreement

Sphere Fluidics announces closure of $2 million (circa £1.5 million) investment round

Sphere Fluidics announces closure of $2 million (circa £1.5 million) investment round

Sphere Fluidics and PAA collaborate to offer automated micro-plate handling capabilities for single cell analysis

Sphere Fluidics and PAA collaborate to offer automated micro-plate handling capabilities for single cell analysis

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics